http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2356199-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bde28565d28f037e78bf4a67776ee24
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-87
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
filingDate 2001-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7a9d0865217cfc10474bf56912d1782
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a50e7c5c0a6e4382eefe1d573b454a43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fab9bd5f2956a73ab96a12ae41662b6c
publicationDate 2001-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-2356199-A
titleOfInvention Production of citalopram in pure form
abstract A process for the preparation of the antidepressant drug citalopram of formula <EMI ID=1.1 HE=42 WI=64 LX=762 LY=549 TI=CF> <PC>in which a compound of formula <B>II</B> <EMI ID=1.2 HE=48 WI=68 LX=748 LY=1175 TI=CF> <PC>wherein Z is iodo, bromo, chloro or CF<SB>3</SB>-(CF<SB>2</SB>)<SB>n</SB>-SO<SB>2</SB>-O- n being 0, 1, 2, 3, 4, 5, 6, 7 or 8, is subjected to a cyanide exchange reaction in which the group Z is exchanged with cyanide by reaction with a cyanide source;<BR> the resultant crude citalopram product is optionally subjected to some initial purification and the crude citalopram base is subsequently subjected to a film distillation process;<BR> the resulting citalopram product is then optionally further purified and worked up and isolated as the base or a pharmaceutically acceptable salt thereof. The film distillation removes high molecular weight impurities.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7365216-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7435838-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03072565-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2376945-A
priorityDate 2000-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0013648-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0011926-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448525428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558592
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10327
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457382234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419511752
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID935
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415796738
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416161973
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5975
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192620
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521617
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449189050
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412550040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8929
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455695671
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID95469
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507269
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31347
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2724144
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450926304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559548
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2734669
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2736962

Total number of triples: 46.